Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC35E4 is a putative nucleotide sugar transporter and member of the solute carrier family 35 (subfamily E) of membrane proteins. It localizes predominantly to the Golgi apparatus and is predicted to mediate transmembrane transport processes, potentially via an antiporter mechanism. The protein’s precise substrate and physiological function remain undefined, and functional characterization is limited; it is classified as an orphan transporter within the SLC35 family. Disease associations are currently minimal, and no drugs or clinical interventions directly interact with SLC35E4.
No drugs are known to target SLC35E4; for the SLC35 family, the mechanism is typically transport of nucleotide-conjugated sugars into the Golgi lumen, but SLC35E4’s substrate and exact mechanism are currently unknown
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 35 member E4 (SLC35E4).